| Pharmaceutical active ingredients: |
| GuaifenesinPhenylephrine Hydrochloride |
| Available forms, composition and doses of Triaminic Chest and Nasal Congestion: |
| Liquid; Oral; Guaifenesin 50 mg; Phenylephrine Hydrochloride 2.5 mg / 5 ml |
| Triaminic Chest and Nasal Congestion medical category: |
| Human:Expectorants |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R01BA53 - Phenylephrine, combinationsR05CA03 - GuaifenesinR05CA10 - Expectorants, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
PhenaVent | Guaifenesin; Phenylephrine Hydrochloride | Ethex |
| Rescon-GG | Guaifenesin; Phenylephrine Hydrochloride | Capellon Pharmaceuticals |
| Simuc | Guaifenesin; Phenylephrine Hydrochloride | Cypress Pharmaceutical |
| Sinupan | Guaifenesin; Phenylephrine Hydrochloride | Ion Laboratories |
| SINUvent PE | Guaifenesin; Phenylephrine Hydrochloride | WE Pharmaceuticals |
| Xpect-PE | Guaifenesin; Phenylephrine Hydrochloride | Cypress Pharmaceutical |
| Kisitex | Guaifenesin; Phenylephrine Hydrochloride; Phenylpropanolamine | A.J. Bart |
| Banex | Guaifenesin; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Lu Chem Pharmaceuticals |
| Coldloc | Guaifenesin; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Fleming Pharmaceuticals |
| Contuss | Guaifenesin; Phenylephrine Hydrochloride; Phenylpropanolamine Hydrochloride | Parmed Pharmaceuticals |